bioMérieux Partners with Ultimate Labs
News Jul 15, 2013
This method, VITEK MS, uses MALDI-TOF mass spectrometry technology to identify bacteria, yeast, and mold, offering significant time savings with respect to traditional identification methods. It is also extremely sensitive, providing a standard of accuracy above many of the current state-of-the art techniques.
“We are extremely pleased to bring this state-of-the-art technology to our customers,” said Kim Lim, CEO of Ultimate Labs. “Our clients adhere to strict safety and quality control regulations issued by governmental agencies such as the USDA and the FDA, and have to be compliant with industry standards. Also, they are eager to identify potential contaminants faster and to increase the sensitivity of their testing. The quantitative protein profiling provided by VITEK MS allows a greatly improved accuracy and time-to-results for our customers," Ms. Lim added. "For our clients where results impact products with short shelf-lives, the faster we can get results to them, the better.”
Bacterial and mold identification are crucial to confirm contaminations and to guide corrective actions in the production of consumable products made by pharmaceutical, cosmetic, and food manufacturers. With 50 years of experience in microbial identification, bioMérieux is the only microbiology company offering a mass spectrometry solution for industry needs. VITEK MS provides fast, flexible, and robust results, and can provide an identification of a microorganism’s genus and species in just a few minutes. As the world leader in microbiology, bioMérieux pairs VITEK MS system with the most comprehensive microbial database in the business.
“Reference laboratories today are striving to improve productivity and shorten their time-to-results,” said Pierre-Louis Thiney, Executive Director US Industry for bioMérieux. “Providing a fully integrated, rapid solution for microbial identification is a significant step in providing timely and accurate results to the customer.”
VITEK MS is available for industrial use and has been submitted for marketing clearance to the FDA for the clinical market.
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Drug Efficacy: Small Differences Cause Great VariationNews
Drugs are not equally effective for everyone. To some extent, this is due to the fact that people's bodies will take up a pharmaceutical substance to varying degrees. A group of researchers have now shed some light on the subject in their report published in the journal Cell Systems.READ MORE